Xilong Scientific's strong revenue growth might underperform...

Xilong Scientific's strong revenue growth might underperform the broader industry, leading to a low P/S ratio. Limited growth rates are expected to persist, reducing investors' willingness to pay for the stock. If recent trends continue, a share price reversal seems unlikely.